Decorative image

Heart Failure Management

Heart Failure Management

Cardiac resynchronization therapy is a proven treatment for selected heart failure patients with a wide QRS. When used in combination with optimal medical therapy, cardiac resynchronization therapy can improves symptoms and extends survival.1-5

Expand All

Clinical Issue

Clinical Issue – Poor Prognosis for Heart Failure Patients with a Wide QRS

Heart failure – related morbidity and mortality remains a major problem6-9

  • Heart failure patients with a wide QRS have poor prognoses6-9
  • Heart failure accounts for over 3.4 million visits to physician offices, hospital outpatient, and emergency departments annually6
  • Heart failure hospitalizations are especially problematic, with one year readmission rates of 50% and mortality rates of approximately 30% 7,8
  • In patients with heart failure, sudden death occurs at four times the rate of the general population9

QRS duration and Left Ventricular Ejection Fraction: Predictors of morbidity and mortality

  • Wide QRS duration is a powerful independent predictor of poor clinical outcomes in patients with HF and reduced left ventricular ejection fraction (LVEF)10
  • QRS durations ≥ 120 ms are associated with a 33% increased risk of all-cause mortality (38% from worsening HF and 31% from sudden death)11
  • Clinical studies show that a low EF is a key predictor of sudden cardiac arrest and an effective way to determine a patient's risk for sudden cardiac arrest (SCA).9,12,13

References

1

Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. April 15, 2005;352(15)1539-1549.

2

Cleland JG, Daubert JC, Erdmann E, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J. August 2006;27(16):1928-1932.

3

Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators. J Card Fail. September 2000;6(3):276-285.

4

Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. June 13, 2002;346(24):1845-1853.

5

Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. May 28, 2003;289(20):2685-2694.

6

Burt CW, Schappert SM. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1999-2000. Vital Health Stat 13. September 2004;(157):1-70.

7

Kosiborod M, Lichtman JH, Heidenreich PA, et al. National trends in outcomes among elderly patients with heart failure. Am J Med. July 2006;119(7):616.e1-7.

8

Rathore SS, Masoudi FA, Wang Y, et al. Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J. August 2006;152(2):371-378.

9

Adabag AS, Therneau TM, Gersh BJ, Weston SA, Roger VL. Sudden death after myocardial infarction. JAMA. 2002;300(17):2022-2029.

10

Hawkins NM, Wang D, McMurray JJ, et al. Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme. Eur J Heart Fail. 2007;9(5):510-517.

11

Wang NC, Maggioni AP, Konstam MA, et al. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA. 2008;299(22):2656-2666.

12

Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440-1463.

13

Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology [published correction appears in Eur Heart J. 2002;23:257]. Eur Heart J. August 2001;22(16):1374-1450.

CRT

CRT Devices

Evidence

Implant

Utilization


IMPORTANT INFORMATION ON INDICATIONS, SAFETY AND WARNINGS

For listing of Indications, Contraindications, Warnings, Precautions, and Potential Adverse Events, please refer to the Instructions For Use .